ISPOR 2023: A Focus on Quality
Prognos Health
MAY 31, 2023
Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth.
2023 Healthcare Leads Pharmaceutical manufacturing 
52 
ISPOR 2023: A Focus on Quality
Prognos Health
MAY 31, 2023
Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Key developments in pharmaceutical manufacturing – September 2023
European Pharmaceutical Review
OCTOBER 12, 2023
September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.
New AMR certification launched for antibiotic manufacturers
European Pharmaceutical Review
JUNE 6, 2023
Standard for antibiotic manufacturing to help combat AMR … Following this “ground-breaking standard” stated Courtney Soulsby, BSI Global Director for Healthcare Sustainability, the certification will “promote responsible pharmaceutical manufacturing and help protect the natural environment and slow antimicrobial resistance”.
Getting ahead of regulatory changes around PFAS in pharmaceutical packaging
Clarivate
MARCH 14, 2024
Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt.
Top 5 Emerging Trends in Pharma Industry
Medico Reach
FEBRUARY 8, 2023
The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing.
Diversity and inclusion in oncology clinical trials
Clarify Health
OCTOBER 26, 2021
The American Medical Association’s 2021-2023 Organizational Strategic Plan to Embed Racial Justice and Advance Health Equity In February 2021, the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research issued new recommendations in five specific areas to broaden oncology trial eligibility criteria to include minorities.
Let's personalize your content